July 5, 2011
by Mark Anderson | firstname.lastname@example.org | 336.758.5237
A new study by researchers at Wake Forest Baptist Medical Center shows that the use of Pfizer’s ChantixTM, a smoking cessation drug, is associated with a 72 percent increased risk of a serious adverse cardiovascular event, such as heart attack or arrhythmia.
Sign up for weekly news highlights.Subscribe
We are Wake Forest University’s primary news source and first point of contact for reporters. We help media by facilitating interviews, connecting with faculty experts or providing interesting story ideas. A staff member is on call 24/7 for media requests at 336.758.5237. Our team also offers a variety of communications resources for Wake Forest students, faculty and staff.